Sushiel Keswani, Executive Director, Ernst & Young LLP to Speak at Knowledge Congress’ Live Webcast
The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Sushiel Keswani, Executive Director, Ernst & Young LLP, will speak at a 2-hour webcast entitled “Sunshine Act: The Final Rule LIVE Webcast.” This event is scheduled for June 24, 2013 from 12pm-2pm (ET).
New York, NY, May 24, 2013 --(PR.com)-- The Knowledge Group/The Knowledge Congress Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Sushiel Keswani, Executive Director, Ernst & Young LLP, will speak at a 2-hour webcast entitled “Sunshine Act: The Final Rule LIVE Webcast.” This event is scheduled for June 24, 2013 from 12pm-2pm (ET).
About Sushiel Keswani
Sushiel is an Executive Director in Ernst & Young’s Americas Advisory Life Sciences practice and leads the Customer Domain services for Life Sciences clients.
Sushiel brings over 8 years of basic research (synthesis of chemical entities), 4 years of manufacturing of packaging for pharmaceuticals and the last 19 years of consulting experience in upstream R&D and downstream Commercial operations of pharmaceutical manufacturers
Sushiel’s areas of focus, both at the country level and global, have been business strategy & transformation, new commercial model design and implementation, customer experience engineering, clinical trial operations optimization, Medical information management, Commercial Agility, enabling technology implementation, complex project management and deployment of solutions for Fortune 100 companies. Sushiel has experience in the following therapeutic areas: Inhalation anaesthetics, Hypoxic Respiratory Failure, Rheumatoid Arthritis, Urinary Incontinence, CV/Metabolics, Neuroscience, Virology and Oncology. Hel leads the Totality of HCP/O/A Spend and PPSA reporting related service offerings for EY in the US for all pharmaceutical clients ranging from readiness assessment to implementation of complete technology enabled solutions.
About Ernst & Young's Advisory Services
The relationship between risk and performance improvement is an increasingly complex and central business challenge, with business performance directly connected to the effective management of risk. Whether your focus is on business transformation or sustaining achievement, having the right advisors can make all the difference. Our 25,000 advisory professionals form one of the broadest global advisory networks of any professional organization, delivering seasoned multidisciplinary teams that work with clients to deliver a powerful and superior client experience. We use proven, integrated methodologies to help you achieve your strategic priorities and make improvements that are sustainable for the longer term.
To know more about Sushiel Keswani and Ernst & Young's Advisory Services please visit: www.ey.com
Event Synopsis:
Compliance for healthcare industry will be completely challenging as the Centers for Medicare & Medicaid Services (CMS) implements Final Rule of Section 6002 of the Affordable Care Act, commonly known as “Sunshine Act.” The provision aims to increase transparency of financial relationships between the industry, healthcare providers and patients.
More specifically, the Sunshine Act requires drug, biological and medical supply manufacturers (including group purchasing organizations (GPOs)) to report, in significant detail, payments made to physicians and other medical institutions to the Federal Government on an annual basis. It also the affected organizations, to report certain ownership or investment interest held by physicians and their immediate family members. Furthermore, the information that will be disclosed will be posted on a public website.
Group Purchasing Organizations, Device Manufacturers, Biotech Companies and Pharmaceutical Companies must have a complete understanding of the Final Rule to avoid penalties and fines.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries. For further details, please visit the organization’s website: www.knowledgecongress.org
About Sushiel Keswani
Sushiel is an Executive Director in Ernst & Young’s Americas Advisory Life Sciences practice and leads the Customer Domain services for Life Sciences clients.
Sushiel brings over 8 years of basic research (synthesis of chemical entities), 4 years of manufacturing of packaging for pharmaceuticals and the last 19 years of consulting experience in upstream R&D and downstream Commercial operations of pharmaceutical manufacturers
Sushiel’s areas of focus, both at the country level and global, have been business strategy & transformation, new commercial model design and implementation, customer experience engineering, clinical trial operations optimization, Medical information management, Commercial Agility, enabling technology implementation, complex project management and deployment of solutions for Fortune 100 companies. Sushiel has experience in the following therapeutic areas: Inhalation anaesthetics, Hypoxic Respiratory Failure, Rheumatoid Arthritis, Urinary Incontinence, CV/Metabolics, Neuroscience, Virology and Oncology. Hel leads the Totality of HCP/O/A Spend and PPSA reporting related service offerings for EY in the US for all pharmaceutical clients ranging from readiness assessment to implementation of complete technology enabled solutions.
About Ernst & Young's Advisory Services
The relationship between risk and performance improvement is an increasingly complex and central business challenge, with business performance directly connected to the effective management of risk. Whether your focus is on business transformation or sustaining achievement, having the right advisors can make all the difference. Our 25,000 advisory professionals form one of the broadest global advisory networks of any professional organization, delivering seasoned multidisciplinary teams that work with clients to deliver a powerful and superior client experience. We use proven, integrated methodologies to help you achieve your strategic priorities and make improvements that are sustainable for the longer term.
To know more about Sushiel Keswani and Ernst & Young's Advisory Services please visit: www.ey.com
Event Synopsis:
Compliance for healthcare industry will be completely challenging as the Centers for Medicare & Medicaid Services (CMS) implements Final Rule of Section 6002 of the Affordable Care Act, commonly known as “Sunshine Act.” The provision aims to increase transparency of financial relationships between the industry, healthcare providers and patients.
More specifically, the Sunshine Act requires drug, biological and medical supply manufacturers (including group purchasing organizations (GPOs)) to report, in significant detail, payments made to physicians and other medical institutions to the Federal Government on an annual basis. It also the affected organizations, to report certain ownership or investment interest held by physicians and their immediate family members. Furthermore, the information that will be disclosed will be posted on a public website.
Group Purchasing Organizations, Device Manufacturers, Biotech Companies and Pharmaceutical Companies must have a complete understanding of the Final Rule to avoid penalties and fines.
About The Knowledge Group, LLC/The Knowledge Congress Live Webcast Series
The Knowledge Congress is a series of live webcasts produced by The Knowledge Group, LLC, which examine trends, regulatory, and technology changes across a variety of industries. Its mission is to produce unbiased, objective, and educational live webcasts that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format.
The organization brings together the world's leading authorities and industry participants through informative two-hour webcasts to study the impact of changes and emerging trends. Hear from leading government officials/regulators, key thought leaders, and industry experts objectively analyze the latest trends and issues and their impact on industries. For further details, please visit the organization’s website: www.knowledgecongress.org
Contact
The Knowledge Congress
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
1.800.578.4370
www.knowledgecongress.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories